The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Iron-Chelating Therapy and the Treatment of Thalassemia
Abstract
Iron-chelating therapy with deferoxamine in patients with thalassemia major has dramatically altered the prognosis of this previously fatal disease. The successes achieved with deferoxamine, as well as the limitations of this treatment, have stimulated the design of alternative strategies of iron-chelating therapy, including orally active iron chelators. The development of the most promising of these, deferiprone, has progressed rapidly over the last 5 years; data from several trials have provided direct and supportive evidence for its short-term efficacy. At the same time, the toxicity of this agent mandates a careful evaluation of the balance between risk and benefit of deferiprone in patients with thalassemia, in most of whom long-term deferoxamine is safe and efficacious therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Free Radical Mechanisms in Tissue Injury
Slater, T. F. (1988) · Cell Function and Disease · doi:10.1007/978-1-4613-0813-3_18 · Cited by 1,555
Free-radical mechanisms in tissue injury
Slater, T. F. (1984) · Biochemical Journal · doi:10.1042/bj2220001 · Cited by 1,538
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,069
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D., & Strohmeyer, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 890
Survival in Medically Treated Patients with Homozygous β-Thalassemia
Olivieri, N. F., Nathan, D. G., MacMillan, J. H., Wayne, A. S., Liu, P. P., McGee, A., Martin, M., Koren, G., & Cohen, A. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310903 · Cited by 852
Self-citationBrittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310902 · Cited by 829
Self-citationBassett, M. L., Halliday, J. W., & Powell, L. W. (1986) · Hepatology · doi:10.1002/hep.1840060106 · Cited by 664
The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism
Keberle, H. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54077.x · Cited by 612
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
Zurlo, M., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Melevendi, C., Piga, A., Di Gregorio, F., Burattini, M., & Terzoli, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90264-x · Cited by 611
Experimental liver cirrhosis induced by alcohol and iron.
Tsukamoto, H., Horne, W., Kamimura, S., Niemelä, O., Parkkila, S., Ylä-Herttuala, S., & Brittenham, G. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118077 · Cited by 513
Self-citationBuja, L. M., & Roberts, W. C. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90240-3 · Cited by 472
Regulators of iron balance in humans [see comments]
Finch, C. (1994) · Blood · doi:10.1182/blood.v84.6.1697.1697 · Cited by 455
Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
Olivieri, N. F., Buncic, J. R., Chew, E., Gallant, T., Harrison, R. V., Keenan, N., Logan, W., Mitchell, D., Ricci, G., Skarf, B., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604033141402 · Cited by 429
Self-citationNon‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity
Hershko, C., Graham, G., Bates, G. W., & Rachmilewitz, E. A. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb03662.x · Cited by 423
IRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA
Pippard, M. J., Warner, G. T., Callender, S. T., & Weatherall, D. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92175-5 · Cited by 419
Hepatic lipid peroxidation in vivo in rats with chronic iron overload.
Bacon, B. R., Tavill, A. S., Brittenham, G. M., Park, C. H., & Recknagel, R. O. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110787 · Cited by 391
Self-citationMagnetic-Susceptibility Measurement of Human Iron Stores
Brittenham, G. M., Farrell, D. E., Harris, J. W., Feldman, E. S., Danish, E. H., Muir, W. A., Tripp, J. H., & Bellon, E. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072703 · Cited by 367
Self-citationBarry, M., Flynn, D. M., Letsky, E. A., & Risdon, R. A. (1974) · BMJ · doi:10.1136/bmj.2.5909.16 · Cited by 326
Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia Major
Olivieri, N. F., Brittenham, G. M., Matsui, D., Berkovitch, M., Blendis, L. M., Cameron, R. G., McClelland, R. A., Liu, P. P., Templeton, D. M., & Koren, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321404 · Cited by 324
Self-citationHereditary Hemochromatosis: Phenotypic Expression of the Disease
Cartwright, G. E., Edwards, C. Q., Kravitz, K., Skolnick, M., Amos, D. B., Johnson, A., & Buskjaer, L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907263010402 · Cited by 300
Lipid peroxide formation in microsomes. The role of non-haem iron
Wills, E. D. (1969) · Biochemical Journal · doi:10.1042/bj1130325 · Cited by 271
Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis
Gutteridge, J. M. C., Rowley, D. A., Griffiths, E., & Halliwell, B. (1985) · Clinical Science · doi:10.1042/cs0680463 · Cited by 271
Brittenham, G. M., Cohen, A. R., McLaren, C. E., Martin, M. B., Griffith, P. M., Nienhuis, A. W., Young, N. S., Allen, C. J., Farrell, D. E., & Harris, J. W. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830420116 · Cited by 270
Self-citationOCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINE
Davies, S., Hungerford, J. L., Arden, G. B., Marcus, R. E., Miller, M. H., & Huehns, E. R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90170-8 · Cited by 270
Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major
Wolfe, L., Olivieri, N., Sallan, D., Colan, S., Rose, V., Propper, R., Freedman, M. H., & Nathan, D. G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122503 · Cited by 265
Self-citationContinuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload
Propper, R. D., Cooper, B., Rufo, R. R., Nienhuis, A. W., Anderson, W. F., Bunn, H. F., Rosenthal, A., & Nathan, D. G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970804 · Cited by 258
Health centres of today; Finsbury, Peckham.
STEWART, A. B., & Williamson, G. S. (1946) · PubMed · Cited by 256
1 Iron toxicity and oxygen radicals
Gutteridge, J. M. C., & Halliwell, B. (1989) · Baillière's Clinical Haematology · doi:10.1016/s0950-3536(89)80017-4 · Cited by 253
Late Cardiac Complications of Chronic, Severe, Refractory Anemia with Hemochromatosis
ENGLE, M. A., ERLANDSON, M., & SMITH, C. H. (1964) · Circulation · doi:10.1161/01.cir.30.5.698 · Cited by 241
Marrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation Therapy
Lucarelli, G., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Andreani, M., Agostinelli, F., Albertini, F., & Clift, R. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291204 · Cited by 227
Merkel, P. A., Simonson, D. C., Amiel, S. A., Plewe, G., Sherwin, R. S., Pearson, H. A., & Tamborlane, W. V. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803313181303 · Cited by 225
Magnetic resonance imaging and spectroscopy of hepatic iron overload.
Stark, D. D., Moseley, M. E., Bacon, B. R., Moss, A. A., Goldberg, H. I., Bass, N. M., & James, T. L. (1985) · Radiology · doi:10.1148/radiology.154.1.3964933 · Cited by 211
Deferoxamine-induced growth retardation in patients with thalassemia major
Virgillis, S. D., Congia, M., Frau, F., Argiolu, F., Diana, G., Cucca, F., Varsi, A., Sanna, G., Podda, G., Fodde, M., et al. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80375-5 · Cited by 210
Plasma ferritin determination as a diagnostic tool.
Finch, C. A., Bellotti, V., Stray, S. M., Lipschitz, D., Cook, J. D., Pippard, M. J., & Huebers, H. A. (1986) · PubMed Central · Cited by 207
Survival and desferrioxamine in thalassaemia major.
Modell, B., Letsky, E. A., Flynn, D. M., Peto, R., & Weatherall, D. J. (1982) · BMJ · doi:10.1136/bmj.284.6322.1081 · Cited by 206
Hemochromatosis and Hemosiderosis: Study of 211 Autopsied Cases
MacDONALD, R. A. (1960) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1960.00270170024004 · Cited by 195
Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers.
Hallaway, P. E., Eaton, J. W., Panter, S. S., & Hedlund, B. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10108 · Cited by 190
Kontoghiorghes, G. J., Aldouri, M. A., Hoffbrand, A. V., Barr, J., Wonke, B., Kourouclaris, T., & Sheppard, L. (1987) · BMJ · doi:10.1136/bmj.295.6612.1509 · Cited by 187
Reassessment of the Use of Desferrioxamine B in Iron Overload
Propper, R. D., Shurin, S. B., & Nathan, D. G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606242942603 · Cited by 180
Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects
Summers, M. R., Jacobs, A., Tudway, D., Perera, P., & Ricketts, C. (1979) · British Journal of Haematology · doi:10.1111/j.1365-2141.1979.tb01167.x · Cited by 179
1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
Kontoghiorghes, G., Sheppard, L., Aldouri, M., & Hoffbrand, A. V. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90545-9 · Cited by 177
A modified transfusion program for prevention of stroke in sickle cell disease
Cohen, A., Martin, M., Silber, J., Kim, H., Ohene-Frempong, K., & Schwartz, E. (1992) · Blood · doi:10.1182/blood.v79.7.1657.1657 · Cited by 175
Olson, L. J., Edwards, W. D., McCall, J. T., Ilstrup, D. M., & Gersh, B. J. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80124-9 · Cited by 171
Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major
Bronspiegel-Weintrob, N., Olivieri, N. F., Tyler, B., Andrews, D. F., Freedman, M. H., & Holland, F. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009133231104 · Cited by 171
Self-citationThe effect of erythroid hyperplasia on iron balance
Pootrakul, P., Kitcharoen, K., Yansukon, P., Wasi, P., Fucharoen, S., Charoenlarp, P., Brittenham, G., Pippard, M., & Finch, C. (1988) · Blood · doi:10.1182/blood.v71.4.1124.1124 · Cited by 168
Self-citationAldouri, M. A., Wonke, B., Hoffbrand, A. V., Flynn, D. M., Ward, S. E., Agnew, J. E., & Hilson, A. J. W. (1990) · Acta Haematologica · doi:10.1159/000205046 · Cited by 165
Al‐Refaie, F. N., Hershko, C., Hoffbrand, A. V., Kosaryan, M., Olivieri, N. F., Tondury, P., & Wonke, B. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05274.x · Cited by 164
Self-citationComparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients
Olivieri, N. F., Freedman, M. H., Koren, G., Hermann, C., Bentur, Y., Chung, D., Klein, J., Olivieri, N. F., Koren, G., Freedman, M. H., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)92962-h · Cited by 162
Self-citationAgarwal, M. B., Gupte, S. S., Viswanathan, C., Vasandani, D., Ramanathan, J., Desai, N., Puniyani, R. R., & Chhablani, A. T. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06445.x · Cited by 162
Nienhuis, A. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101153040311 · Cited by 162
Cardiopulmonary Assessment in Beta-Thalassemia Major
Grisaru, D., Rachmilewitz, E. A., Mosseri, M., Gotsman, M. S., Lafair, J. S., Okon, E., Goldfarb, A., & Hasin, Y. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1138 · Cited by 155
Iron overload cardiomyopathies: New insights into an old disease
Liu, P. J., & Olivieri, N. F. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877096 · Cited by 152
Self-citationMoulds, R. F. W. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91782-1 · Cited by 152
Porter, J. B., Jaswon, M. S., Huehns, E. R., East, C. A., & Hazell, J. W. P. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb07761.x · Cited by 148
Al‐Refaie, F. N., Wonke, B., Hoffbrand, A. V., Wickens, D. G., Nortey, P., & Kontoghiorghes, G. J. (1992) · Blood · doi:10.1182/blood.v80.3.593.593 · Cited by 147
Morehouse, L. A., Thomas, C. E., & Aust, S. D. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90552-6 · Cited by 146
Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging
Kaltwasser, J. P., Gottschalk, R., Schalk, K. P., & Hartl, W. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb02596.x · Cited by 146
Hershko, C., Weatherall, D. J., & Finch, C. (1988) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368809105894 · Cited by 141
Heart cells in culture: a model of myocardial iron overload and chelation.
Link, G., Pinson, A., & Hershko, C. (1985) · PubMed · Cited by 141
Hershko, C., & Peto, T. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.tb01291.x · Cited by 135
Ferrioxamine excretion in iron-loaded man
Pippard, M. J., St, C., & Finch, C. A. (1982) · Blood · doi:10.1182/blood.v60.2.288.288 · Cited by 134
Angelucci, E., BARONCIANI, D., Lucarelli, G., Baldassarri, M., GALIMBERTI, M., Giardini, C., Martinelli, F., Polchi, P., Polizzi, V., Ripalti, M., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb08412.x · Cited by 133
Hypogonadism in Hemochromatosis: Reversal with Iron Depletion
Kelly, T. M., EDWARDS, C. Q., MEIKLE, A. W., & Kushner, J. P. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-5-629 · Cited by 133
Baynes, R., Bezwoda, W. R., Bothwell, T. H., Khan, Q., & Mansoor, N. (1986) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518609083733 · Cited by 133
11 The toxic effects of desferrioxamine
Porter, J. B., & Huehns, E. R. (1989) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(89)80027-7 · Cited by 132
Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia major
Cazzola, M., Stefano, P. D., Ponchio, L., Locatelli, F., Beguin, Y. P., Dessì, C., Barella, S., Cao, A., & Galanello, R. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb08351.x · Cited by 130
Growth Failure and Bony Changes Induced by Deferoxamine
Olivieri, N. F., Koren, G., Harris, J., Khattak, S., Freedman, M. H., Templeton, D. M., Bailey, J. D., & Reilly, B. J. (1992) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199221000-00007 · Cited by 129
Self-citationMyocarditis in β-Thalassemia Major
Kremastinos, D. T., Tiniakos, G., THEODORAKIS, G. N., Katritsis, D. G., & TOUTOUZAS, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.66 · Cited by 129
Liver fibrosis in genetic hemochromatosis
Loréal, O., Deugnier, Y., Moirand, R., Lauvin, L., Guyader, D., Jouanolle, H., Turlin, B., Lescoat, G., & Brissot, P. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80104-7 · Cited by 128
The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes
O'Connell, M. J., Ward, R. J., Baum, H., & Peters, T. J. (1985) · Biochemical Journal · doi:10.1042/bj2290135 · Cited by 128
Olivieri, N. F., Koren, G., Matsui, D. M., Liu, P., Blendis, L. M., Cameron, R., McClelland, R., & Templeton, D. M. (1992) · Blood · doi:10.1182/blood.v79.10.2741.bloodjournal79102741 · Cited by 128
Self-citationTreatment of Cooley's anemia [see comments]
Fosburg, M. T., & Nathan, D. (1990) · Blood · doi:10.1182/blood.v76.3.435.435 · Cited by 126
Kontoghiorghes, G. J., Bartlett, A. N., Hoffbrand, A. V., Goddard, J., Sheppard, L. N., Barr, J., & Nortey, P. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07887.x · Cited by 125
Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning
Tenenbein, M., Kowalski, S., Sienko, A. E., Bowden, D. H., Adamson, I. Y. R., & Tenenbein, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90598-w · Cited by 125
Leon, M. B., BORER, J. S., Bacharach, S. L., Green, M. V., Benz, E. J. J., Griffith, P. M., & Nienhuis, A. W. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911223012103 · Cited by 125
Assessment of tissue iron overload by nuclear magnetic resonance imaging
Johnston, D. L., Rice, L., Vick, G. W., Hedrick, T. D., & Rokey, R. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80481-4 · Cited by 124
Hormonal changes in thalassaemia major.
Flynn, D. M., Fairney, A., Jackson, D., & Clayton, B. E. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.11.828 · Cited by 120
FITCHETT, D. H., COLTART, D. J., Littler, W. A., Leyland, M. J., Trueman, T., Gozzard, D., & Peters, T. J. (1980) · Cardiovascular Research · doi:10.1093/cvr/14.12.719 · Cited by 119
LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA
Modell, C. B., & Beck, J. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb20586.x · Cited by 117
Factors determining glucose tolerance in patients with thalassemia major
Dmochowski, K., Finegood, D. T., Francombe, W. H., Tyler, B. J., & Zinman, B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8345055 · Cited by 116
Clemente, M. G., Congia, M., Lai, M. E., Lilliu, F., Lampis, R., Frau, F., Frau, M. R., Faa, G., Diana, G., Dessì, C., et al. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70138-5 · Cited by 115
Pulmonary Syndrome in Patients With Thalassemia Major Receiving Intravenous Deferoxamine Infusions
Freedman, M. H., Grisaru, D., Olivieri, N., MacLusky, I., & Thorner, P. S. (1990) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1990.02150290059028 · Cited by 114
Self-citationIron Excretion in Thalassaemia Major After Administration of Chelating Agents
Smith, R. S. (1962) · BMJ · doi:10.1136/bmj.2.5319.1577 · Cited by 111
Hussain, M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92035-3 · Cited by 107
DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJOR
Marcus, R. E., Davies, S., Bantock, H. M., Underwood, S. R., Walton, S. P., & Huehns, E. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90439-2 · Cited by 106
Insulin Resistance and Iron Overload
Dandona, P., Hussain, M. A. M., Varghese, Z., Politis, D., Flynn, D. M., & Hoffbrand, A. V. (1983) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328302000203 · Cited by 105
Al‐Refaie, F. N., Wickens, D. G., Wonke, B., Kontoghiorghes, G. J., & Hoffbrand, A. V. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06441.x · Cited by 104
The effects of ascorbic acid on the intracellular metabolism of iron and ferritin.
Bridges, K. R., & Hoffman, K. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67014-0 · Cited by 101
ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR*
O’Brien, R. T. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb20588.x · Cited by 101
Porter, J. B., Morgan, J., Hoyes, K. P., Burke, L., Huehns, E. R., & Hider, R. C. (1990) · Blood · doi:10.1182/blood.v76.11.2389.2389 · Cited by 100
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease
Bonkovsky, H. L., Slaker, D. P., Bills, E. B., & Wolf, D. C. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90629-f · Cited by 100
Mills, K. C., & Curry, S. C. (1994) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(20)30435-1 · Cited by 98
Deferoxamine-induced bone dysplasia in patients with thalassemia major.
Brill, P. W., Winchester, P., Giardina, P. J., & Cunningham-Rundles, S. (1991) · American Journal of Roentgenology · doi:10.2214/ajr.156.3.1899759 · Cited by 97
Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings.
Rahi, A. H. S., Hungerford, J. L., & Ahmed, A. I. (1986) · British Journal of Ophthalmology · doi:10.1136/bjo.70.5.373 · Cited by 94
Transverse relaxation rate enhancement caused by magnetic particulates
Hardy, P., & Henkelman, R. M. (1989) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(89)90549-3 · Cited by 92
Operative Strategy for Pheochromocytomas Localized by [i-131]-M-Iodobenzylguanidine Scintigraphy
Thompson, N., & Gough, I. R. (1984) · The Lancet · Cited by 90
Toxicity of oral iron chelator L1
Berdoukas, V. A., Bentley, P., Frost, H., & Schnebli, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92443-w · Cited by 90
Worwoon, M., Cragg, S. J., Jacobs, A. J., McLaren, C. E., Rickeits, C., & Economidou, J. (1980) · British Journal of Haematology · doi:10.1111/j.1365-2141.1980.tb05987.x · Cited by 89
Chapman, R. W., Hussain, M. A. M., Gorman, A., Laulicht, M., Politis, D., Flynn, D. M., Sherlock, S., & Hoffbrand, A. V. (1982) · Journal of Clinical Pathology · doi:10.1136/jcp.35.5.487 · Cited by 87
Scurvy and Altered Iron Stores in Thalassemia Major
Cohen, A. R., Cohen, I. J., & Schwartz, E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101153040307 · Cited by 86
CECCHETTI, G., Binda, A., Piperno, A., Nador, F., Fargion, S., & FIORELLI, G. (1991) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059873 · Cited by 85
PITUITARY SIDEROSIS. A HISTOLOGIC, IMMUNOCYTOLOGIC AND ULTRASTRUCTURAL STUDY
Bergeron, C., & Kovács, K. (1978) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197809000-00068 · Cited by 85
Early Left Ventricular Dysfunction and Chelation Therapy in Thalassemia Major
Freeman, A. P., GILES, R. W., BERDOUKAS, V. A., WALSH, W. F., CHOY, D., & MURRAY, P. C. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-4-450 · Cited by 84
The British Nutrition Foundation (1995) · Iron · doi:10.1007/978-94-011-0585-9_5 · Cited by 83
Development of iron-chelating agents for clinical use [editorial; comment]
Brittenham, G. (1992) · Blood · doi:10.1182/blood.v80.3.569.bloodjournal803569 · Cited by 82
Self-citationDepletion of excessive liver iron stores with desferrioxamine
Cohen, A. R., Martin, M., & Schwartz, E. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb06096.x · Cited by 82
Uniformity of liver density and nonheme (storage) iron distribution.
Overmoyer, B. A., McLaren, C. E., & Brittenham, G. (1987) · PubMed · Cited by 81
Self-citationAnterior and Posterior Lobes of the Pituitary Gland; Assessment by 1.5 T MR Imaging
Fujisawa, I., Asato, R., Nishimura, K., Togashi, K., Itoh, K., Nakano, Y., Itoh, H., Hashimoto, N., Takeuchi, J., & Torizuka, K. (1987) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198703000-00003 · Cited by 81
Lipid Peroxidation in Iron-Overloaded Spleens
Heys, A. D., & Dormandy, T. L. (1981) · Clinical Science · doi:10.1042/cs0600295 · Cited by 81
Insulin resistance and hyperinsulinemia in homozygous β-thalassemia
Cavallo‐Perin, P., Pacini, G., Cerutti, F., A., B., Condo, C., Sacchetti, L., Piga, A. G., & Pagano, G. (1995) · Metabolism · doi:10.1016/0026-0495(95)90155-8 · Cited by 80
Virgiliis, S. D., Congia, M., Turco, M., Frau, F., Dessì, C., Argiolu, F., Sorcinelli, R., Sitzia, A., & Cao, A. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.3.250 · Cited by 79
Insulin dependent diabetes in thalassaemia.
Sanctis, V. D., Zurlo, M., Senesi, E., Boffa, C., Cavallo, L., & Gregorio, F. D. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.1.58 · Cited by 78
Acute Changes in Renal Function Associated With Deferoxamine Therapy
Koren, G. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150210113029 · Cited by 78
EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINE
Hussain, M. A. M., Green, N., Flynn, D. M., & Hoffbrand, A. V. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92279-6 · Cited by 77
Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study.
Bergeron, C., & Kovács, K. (1978) · PubMed · Cited by 77
Hoffbrand, A. V., Gorman, A. M., Laulicht, M., Garidi, M., Economidou, J., Georgipoulou, P., Hussain, M. A. M., & Flynn, D. M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91721-5 · Cited by 76
Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.
Grundy, R. G., Woods, K. A., Savage, M. O., & Evans, J. P. M. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.2.128 · Cited by 76
Non‐invasive assessment of tissue iron overload in the liver by magnetic resonance imaging
Jensen, P. D., Jensen, F. T., Christensen, T., & Ellegaard, J. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04888.x · Cited by 76
Porter, J. B., Hoyes, K. P., Abeysinghe, R. D., Brooks, P., Huehns, E. R., & Hider, R. C. (1991) · Blood · doi:10.1182/blood.v78.10.2727.2727 · Cited by 76
Evaluation of computed tomography in the assessment of liver iron overload
Guyader, D., Gandon, Y., Deugnier, Y., Jouanolle, H., Loréal, O., Simon, M., Bourel, M., Carsin, M., & Brissot, P. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90646-x · Cited by 76
NEW ORALLY ACTIVE IRON CHELATORS
Kontoghiorghes, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91472-2 · Cited by 75
Bergeron, R. J., Streiff, R., Wiegand, J. S., Luchetta, G. R., Creary, E., & Peter, H. (1992) · Blood · doi:10.1182/blood.v79.7.1882.1882 · Cited by 75
Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload
Rahko, P. S., Salerni, R., & Uretsky, B. F. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80063-8 · Cited by 74
Piperno, A., Fargion, S. R., D’Alba, R., Roffi, L., Fracanzani, A. L., Vecchi, L., Failla, M., & Fiorelli, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80671-3 · Cited by 73
Acute iron poisoning. Rescue with macromolecular chelators.
Mahoney, J. R., Hallaway, P. E., Hedlund, B. E., & Eaton, J. W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114307 · Cited by 72
Kontoghiorghes, G. J., & Hoffbrand, A. V. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb04082.x · Cited by 71
Wang, C., Tso, S. C., & Todd, D. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-511 · Cited by 70
McLaran, C. J., Bett, J. H. N., Nye, J. A., & Halliday, J. W. (1982) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1982.tb02457.x · Cited by 69
Effect of Desferrioxamine and D.T.P.A. in Iron Overload
Bannerman, R. M., Callender, S. T., & Williams, D. L. (1962) · BMJ · doi:10.1136/bmj.2.5319.1573 · Cited by 69
Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy
Cohen, A. R., Mizanin, J., & Schwartz, E. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80353-1 · Cited by 67
Deferiprone‐associated myelotoxicity
Al‐Refaie, F. N., Wonke, B., & Hoffbrand, A. V. (1994) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1994.tb01323.x · Cited by 66
Efficiency of chelated iron compounds as catalysts for the Haber-Weiss reaction
Sutton, H. C. (1985) · Journal of Free Radicals in Biology & Medicine · doi:10.1016/0748-5514(85)90118-7 · Cited by 66
Intensive Iron-Chelation Therapy with Desferrioxamine in Iron-Loading Anaemias
Pippard, M. J., Callender, S. T., & Weatherall, D. J. (1978) · Clinical Science · doi:10.1042/cs0540099 · Cited by 66
Bloomfield, S. E., Markenson, A. L., Miller, D. R., & Peterson, C. M. (1978) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/0191-3913-19780501-08 · Cited by 66
Abnormal glucose tolerance in β-thalassemia major
Saudek, C. D., Hemm, R. M., & Peterson, C. M. (1977) · Metabolism · doi:10.1016/0026-0495(77)90126-3 · Cited by 65
Ferritin in Human Liver Cells of Homozygous Beta‐Thalassaemia: Ultrastructural Observations
Iancu, T. C., & Neustein, H. B. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb01026.x · Cited by 65
BLOOD-GLUCOSE LEVELS AFTER CAFFEINE
Cheraskin, E., & Ringsdorf, W. M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92550-6 · Cited by 65
Iron mobilization from ferritin using α-oxohydroxy heteroaromatic chelators
Kontoghiorghes, G. J. (1986) · Biochemical Journal · doi:10.1042/bj2330299 · Cited by 65
MR Evaluation of Liver Iron Overload
Hernandez, R. J., Sarnaik, S. A., Lande, I., et al. (1988) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198801000-00017 · Cited by 63
Hepatic iron overload: Diagnosis and quantification by noninvasive imaging
CHEZMAR, J. L., Nelson, R. C., MALKO, J. A., & Bernardino, M. E. (1990) · Abdominal Imaging · doi:10.1007/bf01888728 · Cited by 62
The study of iron mobilisation from transferrin using α-ketohydroxy heteroaromatic chelators
Kontoghiorghes, G. J. (1986) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(86)90288-8 · Cited by 62
KWAN, E. Y. W., Lee, A., LI, A. M. C., TAM, S. C. F., Chan, G., Lau, Y., & Low, L. C. K. (1995) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1995.tb00752.x · Cited by 61
Siemons, L., & Mahler, C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-585 · Cited by 60
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?
Pall, H., Blake, D. R., Winyard, P. G., Lunec, J., Williams, A. C., Good, P. A., Kritzinger, E. E., Cornish, A. L., & Hider, R. C. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.1.42 · Cited by 59
Neurosecretory Dysfunction of Growth Hormone Secretion in Thalassemia Major
Shehadeh, N., Hazani, A., RUDOLF, M. C. J., Peleg, I., Benderly, A., & Hochberg, Z. (1990) · Acta Paediatrica · doi:10.1111/j.1651-2227.1990.tb11556.x · Cited by 59
Assessment of bone marrow and body iron stores: old techniques and new technologies.
Gm, B., Eh, D., & Jw, H. (1981) · PubMed · Cited by 59
4 Desferrioxamine-induced iron excretion in humans
Pippard, M. J. (1989) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(89)80020-4 · Cited by 58
Chatterjee, R., Katz, M., Cox, T. F., & Porter, J. B. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02368.x · Cited by 57
VISUAL LOSS IN PATIENT ON HIGH-DOSE SUBCUTANEOUS DESFERRIOXAMINE
Borgna‐Pignatti, C., Stefano, P. D., & Broglia, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92195-0 · Cited by 57
Landau, H., Matoth, I., Landau‐Cordova, Z., et al. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00973.x · Cited by 56
HIGH‐DOSE DESFERRIOXAMINE AS A CAUSE OF GROWTH FAILURE IN THALASSEMIC PATIENTS
Piga, A. G., Luzzatto, L., Capalbo, P., et al. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00198.x · Cited by 56
Iron overload and desferrioxamine chelation therapy in β-thalassemia intermedia
Cossu, P., Toccafondi, C., Vardeu, F., Sanna, G., Frau, F., Lobrano, R., Cornacchia, G., Nucaro, A. L., Bertolino, F., Loi, A., et al. (1981) · European Journal of Pediatrics · doi:10.1007/bf00443255 · Cited by 54
Al‐Refaie, F. N., Wonke, B., Wickens, D. G., Aydınok, Y., Fielding, A. K., & Hoffbrand, A. V. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.7.657 · Cited by 54
Link, G., Athias, P., Grynberg, A., Pinson, A., & Hershko, C. (1989) · PubMed · Cited by 54
Short stature in homozygous β‐thalassaemia is due to disproportionate truncal shortening
Rodda, C. P., Reld, E. D., Johnson, S., Doery, J. C. G., Matthews, R., & Bowden, D. K. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02684.x · Cited by 53
Non-transferrin-bound iron in long-term transfusion in children with congenital anemias
Wang, W. C., Ahmed, N. K., & Hanna, M. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80832-0 · Cited by 53
Chelating Agents in the Diagnosis and Treatment of Iron Overload in Thalassemia
Smith, R. S. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54079.x · Cited by 51
Kontoghiorghes, G. J. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb24321.x · Cited by 50
Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balance
Graziano, J. H., Piomelli, S., Hilgartner, M. W., Giardina, P. J., Karpatkin, M., Andrew, M. E., LoIacono, N. J., & Seaman, C. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80386-1 · Cited by 49
Iron Metabolism in Scurvy with Special Reference to Erythropoiesis*
Bothwell, T. H., Bradlow, B. A., Jacobs, P., Keeley, K. J., Kramer, S., Seftel, H. C., & Zail, S. S. (1964) · British Journal of Haematology · doi:10.1111/j.1365-2141.1964.tb00677.x · Cited by 47
Pyridoxal Isonicotinoyl Hydrazone
Brittenham, G. M. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb24319.x · Cited by 47
Self-citationHershko, C., Link, G., & Pinson, A. (1987) · PubMed · Cited by 47
Valdes‐Cruz, L. M., Reinecke, C., Rutkowski, M. M., Dudell, G. G., Goldberg, S. J., Allen, H. D., Sahn, D. J., & Piomelli, S. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90337-4 · Cited by 43
Carbohydrate Homeostasis and Pancreatic Islet Cell Function in Thalassemia
LASSMAN, M. N., Genel, M., WISE, J. K., HENDLER, R., & FELIG, P. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-1-65 · Cited by 43
Jensen, P. D. Ø., Jensen, F. T., Christensen, T. D., & Ellegaard, J. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb08428.x · Cited by 43
IRON CHELATION WITH ORAL DESFERRIOXAMINE
Callender, S., & Weatherall, D. J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92721-x · Cited by 43
MR relaxation times and iron content of thalassemic spleens: an in vitro study
Gomori, J. M., Grossman, R. I., & Drott, H. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.3.567 · Cited by 42
Non‐Transferrin Plasma Iron in β‐Thalassaemia/Hb E and Haemoglobin H Diseases
Anuwatanakulchai, M., Wasi, P., Pootrakul, P., & Thuvasethakul, P. (1984) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1984.tb02171.x · Cited by 39
Response to long-term deferoxamine therapy in thalassemia
Cohen, A. R., Martin, M., & Schwartz, E. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80385-x · Cited by 38
Sanctis, V. D., D’Ascola, D. G., & Wonke, B. (1986) · Postgraduate Medical Journal · doi:10.1136/pgmj.62.731.831 · Cited by 38
Long, J. A., Doppman, J. L., Nienhus, A. W., & Mills, S. R. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198004000-00005 · Cited by 38
THE MANAGEMENT OF IRON CHELATION THERAPY
Pippard, M. J., & Callender, S. T. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.00503.x · Cited by 37
Noninvasive Methods for the Early Detection of Hereditary Hemochromatosisa
Brittenham, G. M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb55506.x · Cited by 35
Self-citationWeatherall, D. J., Pippard, M. J., & Callender, S. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302243080813 · Cited by 35
Reduction in tissue iron stores with a new regimen of continuous ambulatory intravenous deferoxamine
Olivieri, N. F., Davis, S. A., Liu, P. P., Berriman, A. M., Tyler, B. J., & Francombe, W. H. (1992) · American Journal of Hematology · doi:10.1002/ajh.2830410112 · Cited by 35
Self-citationSchafer, A. I. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360070091015 · Cited by 34
Rowbotham, B., & Roeser, H. P. (1984) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1984.tb05022.x · Cited by 34
Left ventricular function in beta thalassaemia major.
Lau, K. C., Li, A., Hui, P. W., & Yeung, C. Y. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.7.1046 · Cited by 33
Serum Ferritin in Ascorbic Acid Deficiency
Roeser, H. P., Halliday, J. W., Sizemore, D. J., Nikles, A., & Willgoss, D. A. (1980) · British Journal of Haematology · doi:10.1111/j.1365-2141.1980.tb07165.x · Cited by 30
Zevin, S., Link, G., Grady, R. W., Hider, R. C., Peter, H., & Hershko, C. (1992) · Blood · doi:10.1182/blood.v79.1.248.248 · Cited by 27
The Use of Chang Cells Cultured in Vitro to Evaluate Potential Iron Chelating Drugs
White, G. P., Jacobs, A. J., Grady, R. W., & Cerami, A. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03567.x · Cited by 24
Dm, F., Hoffbrand, A. V., & Politis, D. (1982) · PubMed · Cited by 21
Giardina, P. J., Ehlers, K. H., Engle, M. A., Grady, R. W., & Hilgartner, M. W. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb17198.x · Cited by 19
Treatment of Iron Overload in Cooley's Anemiaa
Cohen, A. R., Mizanin, J., & Schwartz, E. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb17197.x · Cited by 18
Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload
Janka, G., M�hring, P., Helmig, M., Haas, R., & Betke, K. (1981) · European Journal of Pediatrics · doi:10.1007/bf00443259 · Cited by 16
Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function
Pattanapanyasat, K., Webster, H. K., Tongtawe, P., Kongcharoen, P., & Hider, R. C. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb04587.x · Cited by 15
Chan, P. C. K., Liu, P. J., Cronin, C. C., Heathcote, J., & Uldall, R. P. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80959-0 · Cited by 14
Combined Subcutaneous and High‐Dose Intravenous Deferoxamine Therapy of Thalassemiaa
Hyman, C. B., AGNESS, C. L., RODRIGUEZ‐FUNES, R., & Zednikova, M. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb17199.x · Cited by 12
The Nature of Serum Iron in Primary Haemochromatosis
Batey, R. G., Fong, P. L. C., & Sherlock, S. (1978) · Clinical Science · doi:10.1042/cs055024pc · Cited by 8
Cited by
Biomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,136
Wood, J. C., Enriquez, C., Ghugre, N., Tyzka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2005) · Blood · doi:10.1182/blood-2004-10-3982 · Cited by 1,045
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
St. Pierre, T. G., Clark, P. R., Chua-anusorn, W., Fleming, A. J., Jeffrey, G. P., Olynyk, J. K., Pootrakul, P., Robins, E., & Lindeman, R. (2005) · Blood · doi:10.1182/blood-2004-01-0177 · Cited by 909
Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31822-6 · Cited by 807
Olivieri, N. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410207 · Cited by 728
Self-citation
Metadata
- Authors
- Olivieri, N. F., & Brittenham, G. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-02-01
- Volume
- 89
- Issue
- 3
- Pages
- 739-761
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1514932744
- Cited by
- 1,089
- References
- 192
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.